Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 46 of 46 entries
Sorted by: Best Match Show Resources per page
Laser-induced convection shifts size distributions in nanoparticle tracking analysis.

Nanoscale advances

Hoffmann WH, Mulkerns NMC, Hall SR, Gersen H.
PMID: 34604699
Nanoscale Adv. 2021 Sep 01;3(19):5694-5702. doi: 10.1039/d1na00572c. eCollection 2021 Sep 28.

This work discusses the effects of increasing laser power on the size data derived from NTA for particles of known size and scatterers in solutions of flufenamic acid in ethanol. We find that whilst a higher laser power reveals...

Cite
Hoffmann WH, Mulkerns NMC, Hall SR, et al. Laser-induced convection shifts size distributions in nanoparticle tracking analysis. Nanoscale Adv. 2021;3(19):5694-5702doi: 10.1039/d1na00572c.
Hoffmann, W. H., Mulkerns, N. M. C., Hall, S. R., & Gersen, H. (2021). Laser-induced convection shifts size distributions in nanoparticle tracking analysis. Nanoscale advances, 3(19), 5694-5702. https://doi.org/10.1039/d1na00572c
Hoffmann, William H, et al. "Laser-induced convection shifts size distributions in nanoparticle tracking analysis." Nanoscale advances vol. 3,19 (2021): 5694-5702. doi: https://doi.org/10.1039/d1na00572c
Hoffmann WH, Mulkerns NMC, Hall SR, Gersen H. Laser-induced convection shifts size distributions in nanoparticle tracking analysis. Nanoscale Adv. 2021 Sep 01;3(19):5694-5702. doi: 10.1039/d1na00572c. eCollection 2021 Sep 28. PMID: 34604699; PMCID: PMC8478152.
Copy Download .nbib Format: NLM
Engineered Hydrophobin as a Crystallization Inhibitor for Flufenamic Acid.

ACS applied bio materials

Sallada N, Li Y, Berger B, Lamm MS.
PMID: 35006868
ACS Appl Bio Mater. 2021 Aug 16;4(8):6441-6450. doi: 10.1021/acsabm.1c00612. Epub 2021 Jul 26.

Hydrophobins are multifunctional, highly surface-active proteins produced in filamentous fungi. Due to their surface-active properties, resistance to degradation, and potential immunological inertness, hydrophobins have been used in many applications such as protein purification, increasing implant biocompatibility, increasing water solubility...

Cite
Sallada N, Li Y, Berger B, et al. Engineered Hydrophobin as a Crystallization Inhibitor for Flufenamic Acid. ACS Appl Bio Mater. 2021;4(8):6441-6450doi: 10.1021/acsabm.1c00612.
Sallada, N., Li, Y., Berger, B., & Lamm, M. S. (2021). Engineered Hydrophobin as a Crystallization Inhibitor for Flufenamic Acid. ACS applied bio materials, 4(8), 6441-6450. https://doi.org/10.1021/acsabm.1c00612
Sallada, Nathanael, et al. "Engineered Hydrophobin as a Crystallization Inhibitor for Flufenamic Acid." ACS applied bio materials vol. 4,8 (2021): 6441-6450. doi: https://doi.org/10.1021/acsabm.1c00612
Sallada N, Li Y, Berger B, Lamm MS. Engineered Hydrophobin as a Crystallization Inhibitor for Flufenamic Acid. ACS Appl Bio Mater. 2021 Aug 16;4(8):6441-6450. doi: 10.1021/acsabm.1c00612. Epub 2021 Jul 26. PMID: 35006868.
Copy Download .nbib Format: NLM
Anti-inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid.

Oncology letters

Soriano-Hernandez AD, Madrigal-Pérez D, Galvan-Salazar HR, Martinez-Fierro ML, Valdez-Velazquez LL, Espinoza-Gómez F, Vazquez-Vuelvas OF, Olmedo-Buenrostro BA, Guzman-Esquivel J, Rodriguez-Sanchez IP, Lara-Esqueda A, Montes-Galindo DA, Delgado-Enciso I.
PMID: 26622892
Oncol Lett. 2015 Oct;10(4):2574-2578. doi: 10.3892/ol.2015.3580. Epub 2015 Aug 07.

Uterine cervical cancer (UCC) is one of the main causes of cancer-associated mortality in women. Inflammation has been identified as an important component of this neoplasia; in this context, anti-inflammatory drugs represent possible prophylactic and/or therapeutic alternatives that require...

Cite
Soriano-Hernandez AD, Madrigal-Pérez D, Galvan-Salazar HR, et al. Anti-inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid. Oncol Lett. 2015;10(4):2574-2578doi: 10.3892/ol.2015.3580.
Soriano-Hernandez, A. D., Madrigal-Pérez, D., Galvan-Salazar, H. R., Martinez-Fierro, M. L., Valdez-Velazquez, L. L., Espinoza-Gómez, F., Vazquez-Vuelvas, O. F., Olmedo-Buenrostro, B. A., Guzman-Esquivel, J., Rodriguez-Sanchez, I. P., Lara-Esqueda, A., Montes-Galindo, D. A., & Delgado-Enciso, I. (2015). Anti-inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid. Oncology letters, 10(4), 2574-2578. https://doi.org/10.3892/ol.2015.3580
Soriano-Hernandez, Alejandro D, et al. "Anti-inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid." Oncology letters vol. 10,4 (2015): 2574-2578. doi: https://doi.org/10.3892/ol.2015.3580
Soriano-Hernandez AD, Madrigal-Pérez D, Galvan-Salazar HR, Martinez-Fierro ML, Valdez-Velazquez LL, Espinoza-Gómez F, Vazquez-Vuelvas OF, Olmedo-Buenrostro BA, Guzman-Esquivel J, Rodriguez-Sanchez IP, Lara-Esqueda A, Montes-Galindo DA, Delgado-Enciso I. Anti-inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid. Oncol Lett. 2015 Oct;10(4):2574-2578. doi: 10.3892/ol.2015.3580. Epub 2015 Aug 07. PMID: 26622892; PMCID: PMC4580029.
Copy Download .nbib Format: NLM
Release of the Non-Steroidal Anti-Inflammatory Drug Flufenamic Acid by Multiparticulate Delivery Systems Promotes Adipogenic Differentiation of Adipose-Derived Stem Cells.

Materials (Basel, Switzerland)

Lazăr AD, Dinescu S, Albu-Kaya MG, Gharbia S, Hermenean A, Costache M.
PMID: 32230892
Materials (Basel). 2020 Mar 27;13(7). doi: 10.3390/ma13071550.

Engineered tissue-like structures often instigate an inflammatory response in the host that can inhibit wound healing and ultimately lead to the rejection of the implant. In our previous study, we have characterized the properties and biocompatibility of novel multiparticulate...

Cite
Lazăr AD, Dinescu S, Albu-Kaya MG, et al. Release of the Non-Steroidal Anti-Inflammatory Drug Flufenamic Acid by Multiparticulate Delivery Systems Promotes Adipogenic Differentiation of Adipose-Derived Stem Cells. Materials (Basel). 2020;13(7)doi: 10.3390/ma13071550.
Lazăr, A. D., Dinescu, S., Albu-Kaya, M. G., Gharbia, S., Hermenean, A., & Costache, M. (2020). Release of the Non-Steroidal Anti-Inflammatory Drug Flufenamic Acid by Multiparticulate Delivery Systems Promotes Adipogenic Differentiation of Adipose-Derived Stem Cells. Materials (Basel, Switzerland), 13(7), . https://doi.org/10.3390/ma13071550
Lazăr, Andreea D, et al. "Release of the Non-Steroidal Anti-Inflammatory Drug Flufenamic Acid by Multiparticulate Delivery Systems Promotes Adipogenic Differentiation of Adipose-Derived Stem Cells." Materials (Basel, Switzerland) vol. 13,7 (2020). doi: https://doi.org/10.3390/ma13071550
Lazăr AD, Dinescu S, Albu-Kaya MG, Gharbia S, Hermenean A, Costache M. Release of the Non-Steroidal Anti-Inflammatory Drug Flufenamic Acid by Multiparticulate Delivery Systems Promotes Adipogenic Differentiation of Adipose-Derived Stem Cells. Materials (Basel). 2020 Mar 27;13(7). doi: 10.3390/ma13071550. PMID: 32230892; PMCID: PMC7178062.
Copy Download .nbib Format: NLM
Human Skin Permeation Enhancement Using PLGA Nanoparticles Is Mediated by Local pH Changes.

Pharmaceutics

Luengo J, Schneider M, Schneider AM, Lehr CM, Schaefer UF.
PMID: 34683901
Pharmaceutics. 2021 Oct 03;13(10). doi: 10.3390/pharmaceutics13101608.

The steady improvement and optimization of transdermal permeation is a constant and challenging pharmaceutical task. In this study the influence of poly(lactide-co-glycolide) (PLGA) nanoparticles on the dermal permeation of the anti-inflammatory drug flufenamic acid (FFA) was investigated. For this...

Cite
Luengo J, Schneider M, Schneider AM, et al. Human Skin Permeation Enhancement Using PLGA Nanoparticles Is Mediated by Local pH Changes. Pharmaceutics. 2021;13(10)doi: 10.3390/pharmaceutics13101608.
Luengo, J., Schneider, M., Schneider, A. M., Lehr, C. M., & Schaefer, U. F. (2021). Human Skin Permeation Enhancement Using PLGA Nanoparticles Is Mediated by Local pH Changes. Pharmaceutics, 13(10), . https://doi.org/10.3390/pharmaceutics13101608
Luengo, Javiana, et al. "Human Skin Permeation Enhancement Using PLGA Nanoparticles Is Mediated by Local pH Changes." Pharmaceutics vol. 13,10 (2021). doi: https://doi.org/10.3390/pharmaceutics13101608
Luengo J, Schneider M, Schneider AM, Lehr CM, Schaefer UF. Human Skin Permeation Enhancement Using PLGA Nanoparticles Is Mediated by Local pH Changes. Pharmaceutics. 2021 Oct 03;13(10). doi: 10.3390/pharmaceutics13101608. PMID: 34683901; PMCID: PMC8538358.
Copy Download .nbib Format: NLM
Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing.

Frontiers in physiology

de Anda-Jáuregui G, Guo K, McGregor BA, Hur J.
PMID: 29545755
Front Physiol. 2018 Mar 01;9:151. doi: 10.3389/fphys.2018.00151. eCollection 2018.

The quintessential biological response to disease is inflammation. It is a driver and an important element in a wide range of pathological states. Pharmacological management of inflammation is therefore central in the clinical setting. Anti-inflammatory drugs modulate specific molecules...

Cite
de Anda-Jáuregui G, Guo K, McGregor BA, et al. Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing. Front Physiol. 2018;9:151doi: 10.3389/fphys.2018.00151.
de Anda-Jáuregui, G., Guo, K., McGregor, B. A., & Hur, J. (2018). Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing. Frontiers in physiology, 9151. https://doi.org/10.3389/fphys.2018.00151
de Anda-Jáuregui, Guillermo, et al. "Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing." Frontiers in physiology vol. 9 (2018): 151. doi: https://doi.org/10.3389/fphys.2018.00151
de Anda-Jáuregui G, Guo K, McGregor BA, Hur J. Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing. Front Physiol. 2018 Mar 01;9:151. doi: 10.3389/fphys.2018.00151. eCollection 2018. PMID: 29545755; PMCID: PMC5838628.
Copy Download .nbib Format: NLM
Enhanced laccase-mediated transformation of diclofenac and flufenamic acid in the presence of bisphenol A and testing of an enzymatic membrane reactor.

AMB Express

Hahn V, Meister M, Hussy S, Cordes A, Enderle G, Saningong A, Schauer F.
PMID: 29478084
AMB Express. 2018 Feb 24;8(1):28. doi: 10.1186/s13568-018-0546-y.

The inadequate removal of pharmaceuticals and other micropollutants in municipal wastewater treatment plants, as evidenced by their detection of these substances in the aquatic environment has led to the need for sustainable remediation strategies. Laccases possess a number of...

Cite
Hahn V, Meister M, Hussy S, et al. Enhanced laccase-mediated transformation of diclofenac and flufenamic acid in the presence of bisphenol A and testing of an enzymatic membrane reactor. AMB Express. 2018;8(1):28doi: 10.1186/s13568-018-0546-y.
Hahn, V., Meister, M., Hussy, S., Cordes, A., Enderle, G., Saningong, A., & Schauer, F. (2018). Enhanced laccase-mediated transformation of diclofenac and flufenamic acid in the presence of bisphenol A and testing of an enzymatic membrane reactor. AMB Express, 8(1), 28. https://doi.org/10.1186/s13568-018-0546-y
Hahn, Veronika, et al. "Enhanced laccase-mediated transformation of diclofenac and flufenamic acid in the presence of bisphenol A and testing of an enzymatic membrane reactor." AMB Express vol. 8,1 (2018): 28. doi: https://doi.org/10.1186/s13568-018-0546-y
Hahn V, Meister M, Hussy S, Cordes A, Enderle G, Saningong A, Schauer F. Enhanced laccase-mediated transformation of diclofenac and flufenamic acid in the presence of bisphenol A and testing of an enzymatic membrane reactor. AMB Express. 2018 Feb 24;8(1):28. doi: 10.1186/s13568-018-0546-y. PMID: 29478084; PMCID: PMC6890904.
Copy Download .nbib Format: NLM
Supramolecular Gels Derived from Simple Organic Salts of Flufenamic Acid: Design, Synthesis, Structures, and Plausible Biomedical Application.

ACS biomaterials science & engineering

Parveen R, Jayamma B, Dastidar P.
PMID: 33405770
ACS Biomater Sci Eng. 2019 May 13;5(5):2180-2189. doi: 10.1021/acsbiomaterials.9b00153. Epub 2019 Apr 15.

Following supramolecular synthon rationale in the context of crystal engineering, a nonsteroidal-anti-inflammatory-drug (NSAID), namely flufenamic acid (

Cite
Parveen R, Jayamma B, Dastidar P. Supramolecular Gels Derived from Simple Organic Salts of Flufenamic Acid: Design, Synthesis, Structures, and Plausible Biomedical Application. ACS Biomater Sci Eng. 2019;5(5):2180-2189doi: 10.1021/acsbiomaterials.9b00153.
Parveen, R., Jayamma, B., & Dastidar, P. (2019). Supramolecular Gels Derived from Simple Organic Salts of Flufenamic Acid: Design, Synthesis, Structures, and Plausible Biomedical Application. ACS biomaterials science & engineering, 5(5), 2180-2189. https://doi.org/10.1021/acsbiomaterials.9b00153
Parveen, Rumana, et al. "Supramolecular Gels Derived from Simple Organic Salts of Flufenamic Acid: Design, Synthesis, Structures, and Plausible Biomedical Application." ACS biomaterials science & engineering vol. 5,5 (2019): 2180-2189. doi: https://doi.org/10.1021/acsbiomaterials.9b00153
Parveen R, Jayamma B, Dastidar P. Supramolecular Gels Derived from Simple Organic Salts of Flufenamic Acid: Design, Synthesis, Structures, and Plausible Biomedical Application. ACS Biomater Sci Eng. 2019 May 13;5(5):2180-2189. doi: 10.1021/acsbiomaterials.9b00153. Epub 2019 Apr 15. PMID: 33405770.
Copy Download .nbib Format: NLM
Zinc Manganate: Synthesis, Characterization, and Electrochemical Application toward Flufenamic Acid Detection.

Inorganic chemistry

Kokulnathan T, Wang TJ, Kumar EA, Liu ZY.
PMID: 33733761
Inorg Chem. 2021 Apr 05;60(7):4723-4732. doi: 10.1021/acs.inorgchem.0c03672. Epub 2021 Mar 18.

The construction of novel electrocatalysts for efficient and economic electrochemical sensors is continuously a significant conceptual barrier for the point-of-care technology. Binary metal oxides with heterostructures have gained plenty of attention due to their promising physicochemical properties. Herein, we...

Cite
Kokulnathan T, Wang TJ, Kumar EA, et al. Zinc Manganate: Synthesis, Characterization, and Electrochemical Application toward Flufenamic Acid Detection. Inorg Chem. 2021;60(7):4723-4732doi: 10.1021/acs.inorgchem.0c03672.
Kokulnathan, T., Wang, T. J., Kumar, E. A., & Liu, Z. Y. (2021). Zinc Manganate: Synthesis, Characterization, and Electrochemical Application toward Flufenamic Acid Detection. Inorganic chemistry, 60(7), 4723-4732. https://doi.org/10.1021/acs.inorgchem.0c03672
Kokulnathan, Thangavelu, et al. "Zinc Manganate: Synthesis, Characterization, and Electrochemical Application toward Flufenamic Acid Detection." Inorganic chemistry vol. 60,7 (2021): 4723-4732. doi: https://doi.org/10.1021/acs.inorgchem.0c03672
Kokulnathan T, Wang TJ, Kumar EA, Liu ZY. Zinc Manganate: Synthesis, Characterization, and Electrochemical Application toward Flufenamic Acid Detection. Inorg Chem. 2021 Apr 05;60(7):4723-4732. doi: 10.1021/acs.inorgchem.0c03672. Epub 2021 Mar 18. PMID: 33733761.
Copy Download .nbib Format: NLM
Piperine, as a TAS2R14 agonist, stimulates the secretion of glucagon-like peptide-1 in the human enteroendocrine cell line Caco-2.

Food & function

Huang TT, Gu PP, Zheng T, Gou LS, Liu YW.
PMID: 34881772
Food Funct. 2022 Jan 04;13(1):242-254. doi: 10.1039/d1fo02932k.

Piperine is reported to ameliorate common metabolic diseases, however, its molecular mechanism is still unclear. In the present study, we examined whether piperine could stimulate glucagon-like peptide-1 (GLP-1) secretion in a human enteroendocrine cell line, Caco-2, and explored the...

Cite
Huang TT, Gu PP, Zheng T, et al. Piperine, as a TAS2R14 agonist, stimulates the secretion of glucagon-like peptide-1 in the human enteroendocrine cell line Caco-2. Food Funct. 2022;13(1):242-254doi: 10.1039/d1fo02932k.
Huang, T. T., Gu, P. P., Zheng, T., Gou, L. S., & Liu, Y. W. (2022). Piperine, as a TAS2R14 agonist, stimulates the secretion of glucagon-like peptide-1 in the human enteroendocrine cell line Caco-2. Food & function, 13(1), 242-254. https://doi.org/10.1039/d1fo02932k
Huang, Ting-Ting, et al. "Piperine, as a TAS2R14 agonist, stimulates the secretion of glucagon-like peptide-1 in the human enteroendocrine cell line Caco-2." Food & function vol. 13,1 (2022): 242-254. doi: https://doi.org/10.1039/d1fo02932k
Huang TT, Gu PP, Zheng T, Gou LS, Liu YW. Piperine, as a TAS2R14 agonist, stimulates the secretion of glucagon-like peptide-1 in the human enteroendocrine cell line Caco-2. Food Funct. 2022 Jan 04;13(1):242-254. doi: 10.1039/d1fo02932k. PMID: 34881772.
Copy Download .nbib Format: NLM
Showing 37 to 46 of 46 entries